Potential risks of glucagon stimulation test in elderly people.

Author: ConceiçãoFlávia Lucia, PaixãoCarlos Montes, Seixas-da-SilvaIgnácio Antônio, SilvestreDiego H S, TavaresAna Beatriz Winter, VaismanMario

Paper Details 
Original Abstract of the Article :
UNLABELLED: The glucagon stimulation test (GST) is a reliable measure for assessing growth hormone (GH) and adrenocorticotropic hormone (ACTH) secretion. The GST is considered to be a safe test, with few mild side effects, especially in adults and in the elderly in whom underlying co-morbidities may...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ghir.2014.11.002

データ提供:米国国立医学図書館(NLM)

Glucagon Stimulation Test: A Careful Approach for Elderly Patients

In the realm of geriatric medicine, researchers are constantly seeking ways to understand and address the unique health needs of older adults. This research, like a camel navigating a desert, investigates the potential risks of the glucagon stimulation test (GST) in elderly patients. The researchers conducted a study involving 42 subjects aged 67-88 years, finding that while GST is a reliable measure for assessing growth hormone (GH) and adrenocorticotropic hormone (ACTH) secretion, it carries a higher risk of side effects, such as nausea, hypotension, and even seizures, in elderly patients. The study emphasizes the need for careful consideration of patient factors and the potential for adverse events when administering the GST to elderly individuals.

Navigating the Desert of Geriatric Medicine: Careful Consideration for the Glucagon Stimulation Test

The study's findings raise important concerns regarding the use of GST in elderly patients. The researchers found a significant correlation between side effects and higher peak cortisol and GH levels. This highlights the importance of carefully assessing patient factors, such as co-morbidities and medication history, before administering the GST to elderly patients. The study emphasizes the need for close monitoring and prompt intervention in case of adverse events.

A Desert Oasis of Safe Testing: Ensuring Safe Procedures for Elderly Patients

The study serves as a reminder that even seemingly routine tests can pose unique challenges for elderly patients. It is essential to prioritize patient safety and tailor procedures, like the GST, to the specific needs and vulnerabilities of older individuals. As Dr. Camel, I believe that this research promotes a more cautious and personalized approach to medical testing in elderly patients, ensuring that procedures are administered safely and effectively.

Dr.Camel's Conclusion

This research investigates the potential risks of the glucagon stimulation test (GST) in elderly patients. The study findings suggest that GST, while a reliable test for assessing GH and ACTH secretion, carries a higher risk of side effects in elderly patients, highlighting the need for careful consideration of patient factors and the potential for adverse events.
Date :
  1. Date Completed 2015-09-09
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25481820

DOI: Digital Object Identifier

10.1016/j.ghir.2014.11.002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.